Primary bone lymphoma of the mandible and thyroid incidentaloma identified by18FDG PET/CT: A case report

Cases Journal

Volumn 2, Issue 6, 2009, Pages

  Bosch Barrera, Joaquim ^a   Arbea, Leire ^a   García Velloso, Maria J ^a   Gil Bazo, Ignacio ^a   García Foncillas, Jesús ^a   Panizo, Carlos ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; ASPIRATION BIOPSY; BONE ATROPHY; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MANDIBLE; NONHODGKIN LYMPHOMA; PAPILLARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIMARY BONE LYMPHOMA; THYROID CARCINOMA; THYROID INCIDENTALOMA; THYROIDECTOMY;

EID: 77953379472     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.4076/1757-1626-2-6384     Document Type: Article

References (15)

1. Limb D, Dreghorn C, Murphy JK, Mannion R: Primary lymphoma of bone. Int Orthop 1994, 18:180-183.
2. Beal K, Allen L, Yahalom J: Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer 2006, 106:2652-2656.
3. Zinzani PL, Carrillo G, Ascani S, Barbieri E, Tani M, Paulli M et al.: Primary bone lymphoma: experience with 52 patients. Haematologica 2003, 88:280-285.
4. Fidias P, Spiro I, Sobczak ML, Nielsen GP, Ruffolo EF, Mankin H et al.: Long-term results of combined modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys 1999, 45:1213-1218.
5. Coiffier B: Rituximab in the treatment of diffuse large B-cell lymphomas. Semin Oncol 2002, 29:30-35.
6. Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Ferme C et al.: Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2005, 23:4117-4126.
7. Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K et al.: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006, 7:379-391.
8. Jhanwar YS, Straus DJ: The role of PET in lymphoma. J Nucl Med 2006, 47:1326-1334.
9. Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, Lee IG et al.: Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003, 88:4100-4104.
10. Palmedo H, Bucerius J, Joe A, Strunk H, Hortling N, Meyka S et al.: Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. J Nucl Med 2006, 47:616-624.
11. Stokkel MP, Duchateau CS, Dragoiescu C: The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature. Q J Nucl Med Mol Imaging 2006, 50:78-87.
12. Rathmell AJ, Gospodarowicz MK, Sutcliffe SB, Clark RM: Localised lymphoma of bone: prognostic factors and treatment recommendations. The Princess Margaret Hospital Lymphoma Group. Br J Cancer 1992, 66:603-606.
13. Someya M, Sakata K, Nagakura H, Itou K, Nakata K, Oouchi A et al.: Three cases of diffuse large B-cell lymphoma of the mandible treated with radiotherapy and chemotherapy. Radiat Med 2005, 23:296-302.
14. Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Grogan TM et al.: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998, 339:21-26.
15. Yahalom J, Varsos G, Fuks Z, Myers J, Clarkson BD, Straus DJ: Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study. Cancer 1993, 71:2342-2350.